Clinical Supply Management Solutions

  1. Simplify EDC Workflow With Integrated Randomization 1/30/2026

    By unifying randomization and data collection into a single solution with a single sign-on, this service eliminates the need for complex data reconciliation between separate platforms.

  2. Keep Your Clinical Trials On Track 12/5/2024

    This RTSM solution platform supports end-to-end study management, offering enhanced visibility, tracking, and automation to optimize the trial lifecycle.

  3. How Can Phase 1 Trials Employ eClinical Solutions? 1/8/2024

    Uncover how this unified platform is helping sponsors and CROs generate high-quality data, accelerate trials, and rapidly scale to Phase 2 and beyond.

  4. RTSM Master 1/27/2023

    Our self-service and full-service-enabled, efficient trial building functionality offers you a customized experience without the custom price tag.

  5. Prancer RTSM: 100% Configurable & Flexible 1/7/2022

    Explore how Prancer RTSM utilizes natural language processing (NLP) and integrated supply forecasting to address the rising complexities and challenges of clinical trials.

  6. Clinical Trials Comparator And Co-Medication Sourcing Services

    Learn how Thermo Fisher Scientific's Comparator Center of Excellence Team can assist you with developing the most cost effective strategy for securing the medications locally, regionally, globally or a combination.

  7. Tailored CDMO And Clinical Supply Solutions For Complex Needs 1/26/2026

    Integrated analytical, manufacturing, packaging, and distribution capabilities streamline development and supply. Broad expertise and flexible services reduce handoffs and support efficient progress.

  8. Adding eCOA To RTSM: Simplifying Workflow For Sites 12/9/2024

    Simplify trials with Signant’s integrated SmartSignals eCOA and RTSM. Eliminate duplication, reduce reconciliation, and streamline operations for faster, error-free studies.

  9. Navigating The Use Of Controlled Substances In Clinical Trials Using IRT

    Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.

  10. The Path To Proof, Reimagined 5/15/2024

    By combining technology with clinical and operational expertise, Signant Health prioritizes the clinical research stakeholder experience, making it more intuitive, while ensuring the data journey is direct.